Author:
Xu Chun-wei,Lei Lei,Wang Wen-xian,Lin Li,Zhu You-cai,Wang Hong,Miao Li-yun,Wang Li-ping,Zhuang Wu,Fang Mei-yu,Lv Tang-feng,Song Yong
Funder
Zhejiang Public Welfare Technology Research Program
Science and Technology Planning project of Zhejiang Province
Medical Scientific Research Foundation of Zhejiang Province of China
Zhejiang Traditional Chinese Medicine Science Fund Project
Scientific Research Foundation of Zhejiang Medical Association
Xisike-Hanson Cancer Research Foundation
Reference23 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018
2. Cancer statistics, 2019;Siegel;CA Cancer J. Clin.,2019
3. Chemotherapy for non–small cell lung cancer: have we reached a new plateau?;Shepherd;Semin. Oncol.,1999
4. L, Chen G, et al. Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non–small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study;Zhou;Lancet Oncol.,2011
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献